Table 2 Number, prevalence (95% CI) of participants defined as gout cases
From: Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
Definition | No. of subjects, prevalence (95% CI) in entire study population (n = 105,421) | No. of subjects, prevalence (95% CI) in male participants (n = 51,844) | No. of subjects, prevalence (95% CI) in female participants (n = 53,577) | Percentage (95% CI) of study population with gout using any definition (n = 2432) |
|---|---|---|---|---|
Self-report of gout diagnosis | 2066, 1.96% (1.88–2.05) | 1921, 3.70% (3.55–3.87) | 145, 0.27% (0.23–0.32) | 84.95% (83.49–86.33) |
ULT use | 1652, 1.57% (1.49–1.64) | 1529, 2.95% (2.81–3.10) | 123, 0.23% (0.19–0.27) | 67.93% (66.05–69.75) |
Hospital diagnosis | 382, 0.36% (0.33–0.40) | 346, 3.29% (3.14–3.45) | 36, 0.07% (0.05–0.09) | 15.71% (14.32–17.21) |
Winnard definition [5]a | 1861, 1.76% (1.69–1.85) | 1707, 3.29% (3.14–3.45) | 154, 0.29% (0.25–0.34) | 76.52% (74.80–78.16) |
Self-report of gout or ULT use | 2295, 2.18% (2.09–2.27) | 2122, 4.09% (3.93–4.27) | 173, 0.32% (0.28–0.37) | 94.37% (93.38–95.22) |